Le Lézard
Classified in: Health
Subject: AWD

Ramzan M. Zakir, M.D., F.A.C.C., FSCAI is recognized by Continental Who's Who


NEW BRUNSWICK, N.J., Jan. 15, 2019 /PRNewswire/ -- Ramzan M. Zakir, M.D., F.A.C.C., FSCAI is recognized by Continental Who's Who as 2018 Cardiologist of The Year in the field of Medicine in recognition of his role as Interventional Cardiologist at Heart & Vascular Institute of Central New Jersey.

With quality, comprehensive health care at the forefront of the company's values, Heart and Vascular Institute of Central Jersey is dedicated to serving their clients through the implementation of the latest innovations in the medical industry. The Heart and Vascular institute "believe in developing a strong relationship," with their patients, "based on compassion, mutual respect and understanding."  A trusted name in the medical industry, the institute uses, "exceptional diagnostic services to help initiate a focused, personalized treatment plan to improve your health condition."  The facility is adept in handling medical matters with regards to Coronary Artery Disease, Congestive Heart Failures, Valvular Heart Disease, Cardiomyopathies, and more.

Since 2009, Dr. Zakir has performed thousands of successful angioplasty procedures in his role as interventional cardiologist.  Expanding his practice to peripheral vascular diseases, Dr. Zakir is board certified in cardiology, vascular medicine, nuclear medicine, and has recently obtained his PVI certificate for vascular ultrasound. Heart and Vascular Institute of Central Jersey is where Dr. Zakir can assess the needs of his patients prior to performing complex coronary interventions, chronic total occlusions, carotid artery stenting and endovascular interventions for patients with peripheral vascular diseases as well as venous ablations for venous insufficiency.

Early in his career, Dr. Zakir attended Rutgers College and completed both his internship and residency at UMDNJ ? New Jersey Medical School, and served as Chief Medical Resident through the program at Hackensack University Hospital. Board Certified in Internal Medicine, Cardiovascular Disease, Interventional Cardiology, Echocardiography Nuclear Cardiology and Endovascular, Dr. Zakir is fluent in Urudu, Punjabi Hindi, and English.

Clinical Assistant Professor of Medicine at Rutgers Medical School ? Robert Wood Johnson University Hospital, Dr. Zakir is involved in research and fellow training. Director of the Peripheral Vascular Program at Saint Peter's University Hospital, Dr. Zakir serves as principal investigator of several clinical trials to enhance the management of patients with peripheral arterial disease. In his previous capacity, Dr. Zakir served as the Director of Transradial Catherization at Robert Wood Johnson University Hospital, from 2011 to 2016.

To further advance his professional career, Dr. Zakir is an affiliate of several organizations including the American College of Cardiology, a Fellow of the Society for Cardiac Angiography and Intervention, and a member of the Police Defense Foundation as well as Health Forces for Police.
An illustrious scholar, Dr. Zakir is known for his distinct contributions to prominent medical publications.

When not working, Dr. Zakir enjoys tennis, basketball, football, and rooting for the New York Jets, Knicks and Yankees.

Dr. Zakir dedicates this recognition to his father, Mirza, and to Saud Sadiq.
For more information, visit www.NJHeartandvascular.com.

Contact: Katherine Green, 516-825-5634, [email protected]

SOURCE Continental Who's Who


These press releases may also interest you

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

3 jui 2024
On July 02, 2024, the BC Government designated Psychotherapy as a Health Profession under the Health Professions Act. The proposal received cabinet approval and was subsequently signed by the Lieutenant Governor. The official order can be viewed...

3 jui 2024
Whitman-Walker Institute condemns the politically motivated ruling from a federal district court judge that blocks vital nondiscrimination protections for transgender people across the country. Today, a U.S. district court judge in Mississippi issued...



News published on and distributed by: